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Abstract 
Limbal microvascular endothelial cells (L-MVEC) contribute to formation of the corneal-
limbal stem cell niche and to neovascularization of diseased and injuries corneas. 
Nevertheless, despite these important roles in corneal health and disease, few attempts have 
been made to isolate L-MVEC with the view to studying their biology in vitro. We therefore 
explored the feasibility of generating primary cultures of L-MVEC from cadaveric human 
tissue. We commenced our study by evaluating growth conditions (MesenCult-XF system) 
that have been previously found to be associated with expression of the endothelial cell 
surface marker thrombomodulin/CD141, in crude cultures established from collagenase-
digests of limbal stroma. The potential presence of L-MVEC in these cultures was examined 
by flow cytometry using a more specific marker for vascular endothelial cells, 
CD31/PECAM-1. These studies demonstrated that the presence of CD141 in crude cultures 
established using the MesenCult-XF system is unrelated to L-MVEC. Thus we subsequently 
explored the use of magnetic assisted cell sorting (MACS) for CD31 as a tool for generating 
cultures of L-MVEC, in conjunction with more traditional endothelial cell growth conditions. 
These conditions consisted of gelatin-coated tissue culture plastic and MCDB-131 medium 
supplemented with fetal bovine serum (10% v/v), D-glucose (10 mg/mL), epidermal growth 
factor (10 ng/mL), heparin (50 µg/mL), hydrocortisone (1 µg/mL) and basic fibroblast growth 
factor (10 ng/mL). Our studies revealed that use of endothelial growth conditions are 
insufficient to generate significant numbers of L-MVEC in primary cultures established from 
cadaveric corneal stroma. Nevertheless, through use of positive-MACS selection for CD31 
we were able to routinely observe L-MVEC in cultures derived from collagenase-digests of 
limbal stroma. The presence of L-MVEC in these cultures was confirmed by immunostaining 
for von Willebrand factor (vWF) and by ingestion of acetylated low-density lipoprotein. 
Moreover, the vWF+ cells formed aligned cell-to-cell ‘trains’ when grown on Geltrex™. The 
purity of L-MVEC cultures was found to be unrelated to tissue donor age (32 to 80 years) or 
duration in eye bank corneal preservation medium prior to use (3 to 10 days in Optisol) (using 
multiple regression test). Optimal purity of L-MVEC cultures was achieved through use of 
two rounds of positive-MACS selection for CD31 (mean ± s.e.m, 65.0 ± 20.8%; p<0.05). We 
propose that human L-MVEC cultures generated through these techniques, in conjunction 
with other cell types, will provide a useful tool for exploring the mechanisms of blood vessel 
cell growth in vitro. 
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Highlights 
• MACS supports isolation of microvascular endothelial cells from human corneal 
limbus. 
• Neither donor age (31-80 years) nor time in storage (2 -11 days) effect culture purity. 
• Optimal purity of cultures is achieved using two rounds of positive selection for 
CD31. 
• The cultures express vWF, endocytose acetylated LDL and form cell trains on 
Geltrex™. 
 
 
 
 
 
Keywords (up to 8) 
Corneal limbus, microvascular endothelial cells, magnetic assisted cell sorting (MACS), 
CD31/PECAM-1, cell culture, von Willebrand factor (vWF). 
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Abbreviations 
 
CD  Cluster of differentiation cell surface marker 
DMEM Dulbecco’s modification of Eagle’s medium 
ECM  Extracelullar matrix 
F12  Ham’s F12 medium 
FBS  Foetal bovine serum 
HBS  Hepes buffered saline 
HUVEC Human umbilical vein endothelial cell 
LDL  Low density lipoprotein 
L-MVEC Limbal microvascular endothelial cells 
MACS  Magnetic assisted cell sorting 
PBS  Phosphate buffered saline 
PECAM-1 Platelet endothelial cell adhesion marker-1 
vWF  von Willebrand factor 
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Introduction 
 
Microvascular endothelial cells of the corneal limbus (L-MVEC) facilitate blood supply to the 
peripheral tissues of the cornea including the limbal epithelial stem cell niche (Dua et al., 
2005, Stepp and Zieske, 2005). Under normal circumstances L-MVEC remain quiescent 
within the limbal palisades of Vogt. Corneal inflammation, however, encourages the growth 
of blood vessels into the normally avascular cornea, thus contributing to vision impairment 
(Stevenson et al., 2012). Studies of L-MVEC function are therefore of major significance to 
both corneal health (stem cell niche) and disease (neovascularization). 
 
For many years, the so-called corneal micro-pocket assay, utilized in animal models (Rogers 
et al., 2007, Ziche and Morbidelli, 2009), has provided a valuable tool for studying corneal 
neovascularization and mechanisms of angiogenesis more generally. Nevertheless, live 
animal experiments are relatively expensive to conduct and exploration of alternatives is 
encouraged by national standards for the conduct of research in animals (NH&MRC, 2013). 
In vitro models of human L-MVEC function therefore offer a novel, relatively inexpensive, 
and ethically responsible tool for vascular drug development. Surprising, however, few 
attempts have been made to isolate and cultivate L-MVEC from human tissue (Li et al., 
2012a, Marceau et al., 1990). Moreover, there have been significant variations in the methods 
used and observations made. 
 
Marceau and colleagues (Marceau et al., 1990) first reported a method for the isolation and 
culture of human L-MVEC based upon use of limbal tissue explants grown under conditions 
designed to encourage vascular endothelial cell growth. The resulting cultures initially 
displayed a “cobblestone” morphology, but became mesenchymal with time and passaging. 
The authors concluded that the majority of passaged cells were L-MVEC based upon 
immunoreactivity (immunocytochemistry and flow cytometry) towards an antibody to factor 
VIII-related antigen/von Willebrand factor (vWF). 
 
More recently, Garfias et al. (Garfias et al., 2012) have noted that crude cultures established 
from collagenase-digests of human limbal stroma, display “tubule formation” in a dose 
dependent manner when grown on Matrigel® and exposed to vascular endothelial growth 
factor (VEGF). While no staining for endothelial cell markers was reported, the authors 
concluded that the apparent tubule formation (defined as the number of cell to cell 
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connections and “tubular reticulum formation”) provided evidence of an ability to produce 
capillary-like structures in culture.  
 
In a series of other recent studies, Li et al. (2012a, 2012b) have reported the presence of “cells 
expressing angiogenesis markers” in collagenase-digests of human limbal stroma. The 
markers observed initially by immunocytochemistry included CD31/platelet endothelial cell 
adhesion marker-1 (PECAM-1) and vWF. Interestingly, while negligible levels of CD31 
expression were subsequently detected in cultures grown on either tissue culture plastic or 
Matrigel®, these same cells increased expression of angiogenic markers within one week of 
being grown within a 3D extracellular matrix (ECM) composed of Matrigel®. Moreover, 
once passaged back onto tissue culture plastic and grown in an endothelial growth medium, 
the cells stained positively for vascular endothelial cell markers (including CD31 and vWF) 
and were able to endocytose acetylated low-density lipoprotein, a standard technique for 
identifying endothelial cells in culture (Scott and Bicknell, 1993).  
 
Our own recent studies (Bray et al., 2012, Bray et al., 2014) have revealed that cultures 
derived from collagenase-digests of human limbal stroma contain significant numbers of cells 
expressing CD141/thrombomodulin (approximately 40% by flow cytometry), when grown in 
a commercial serum-free medium designed for bone marrow-derived mesenchymal stromal 
cells (MesenCult-XF, Stem Cell Technologies). While the cell surface marker CD141 is not 
exclusively found on vascular endothelial cells, its expression is consistent with a vascular 
endothelial phenotype and thus it is possible that we may have discovered a relatively simple 
technique to increase the survival and potential propagation of L-MVEC in culture. 
 
In consideration of the above literature, we have designed a study to re-evaluate the feasibility 
of establishing cultures of L-MVEC from surgical off-cuts of cadaveric human corneal 
limbus. We commence by testing our previously characterised CD141-positive cultures 
(established using the MesenCult-XF culture system) for evidence of L-MVEC, through 
investigation of a more specific marker, CD31/PECAM-1. Secondly, we have utilized 
magnetic assisted cell sorting (MACS) as a tool for purifying the CD31-positive fraction 
observed by Li et al. (2012b) from collagenase-digests of limbal stroma. Using tissue from 27 
separate donors we have progressively modified our MACS technique with the aim to 
optimizing the purity of isolated L-MVEC. The resulting cultures were examined for evidence 
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of both L-MVEC phenotype (vWF expression) and function (uptake of acetylated-LDL and 
morphology on Geltrex™). 
 
Materials and methods 
 
Analysis of established limbal stromal cultures for CD31. 
Cultures of limbal stromal cells were established from recently characterized stocks (Bray et 
al., 2014). In brief, paired cultures from three donors had been established and passaged once 
in either serum-supplemented culture medium (10% v/v FBS) or using the MesenCult-XF 
culture system (Stem Cell Technologies). These cultures had been previously determined by 
flow cytometry to be of predominantly mesenchymal phenotype by co-expression of CD73, 
CD90 and CD105, with low expression of CD34 and CD45. Importantly, approximately 40% 
of the limbal stromal cells (LSC) grown in MesenCult-XF expressed CD141/thrombomodulin 
compared to <5% for cells cultured in the presence of 10% (v/v) FBS. Presently, samples of 
each culture type were retrieved from storage in liquid nitrogen and re-established in their 
respective media for approximately 1 week prior to measurement of CD31 expression. The 
presence of CD31 on the cell surface was determined by flow cytometry as described 
previously (Bray et al., 2012, Bray et al., 2014) using a phycoerythrin (PE)-conjugated mouse 
anti-human IgG1 κ antibody raised against human CD31 (eBioscience Cat. No. 12-0319; 
Jomar Bioscience). The PE IgG1 κ isotype control used (clone MOPC-21) was purchased 
from BD Biosciences (Cat No. 555749). Our earlier panel of antibodies to cell surface 
antigens including CD141 was also repeated (as described in (Bray et al., 2014)). Cell 
viability was assessed using 7AAD solution (BD Biosciences, Cat No. 559925). Fifty 
thousand events were collected per sample on a BD LSRII and analysed using FlowJo version 
10 software (Tree Star Inc, Ashland, OR, USA). Human umbilical vein endothelial cells 
(HUVEC; Life Technologies Cat. No. C0035C) grown in endothelial growth medium (refer 
below) were utilized as the positive control.  
 
Establishment of new test cultures from limbal stroma 
Human corneoscleral rims were obtained with human research ethics committee approval 
(QUT Approval No. 0800000807) and donor consent obtained through the Queensland Eye 
Bank (QEB, Brisbane, Australia). Prior to digestion, the tissue was dissected down to a 2 mm 
diameter section across the limbal transition between transparent cornea and opaque sclera. 
The tissue was then washed in three changes of PBS to remove eye bank storage medium 
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(Optisol, Chiron Ophthalmics) then digested with 0.25% Dispase II (Gibco/Life Technologies 
Cat. No. 17105-041) for 1 hour at 37 °C, followed by debridement of the anterior and 
posterior surfaces using forceps, to remove the limbal epithelium and traces of peripheral 
corneal endothelium and trabecular meshwork. The remaining stroma was minced finely 
using a scalpel blade and digested in 1 mg/mL collagenase type 1 (Gibco/Life Technologies, 
Cat. No. 17100-017) in DMEM/F12 medium for 48 hours prior to washing and either re-
suspension in culture medium (donors 1 to 3) or processing for MACS (donors 4 to 27). 
 
Test cultures of limbal stromal cells were grown in 24-well culture plates with one well (~1.8 
cm2) being used for each isolated fraction. Culture plates were pre-treated with Attachment 
Factor Protein (Gibco/Life Technologies Cat. No. S-006-100) according to manufacturer’s 
instructions. The culture medium (endothelial growth medium) consisted of MCDB-131 
supplemented with 10% (v/v) FBS, 10 mM L-glutamine, 10 ng/mL epidermal growth factor, 
1 µg/mL hydrocortisone, 50 µg/mL heparin, 12.5 ng/mL basic fibroblast growth factor, 10 
mg/mL D-glucose and penicillin/streptomycin solution (100 IU/mL/100 µg/mL). The primary 
cultures were grown for approximately 1 week with the medium being changed every 2 to 3 
days. Passaging of cultures was attempted using 0.25% trypsin/0.02% EDTA.  
 
Magnetic assisted cell sorting (MACS) 
Collagenase-digests of limbal stroma were first passed through a 100 µm filter followed by a 
40 µm filter in an effort to remove clumps of debris and non-digested tissue. Between 10,000-
30,000 cells were isolated from each tissue digest. For Donors 10-27, digests were 
subsequently treated with an equal volume of Versene solution (Gibco/Life Technologies Cat. 
No. 150040) and triturated 3-5 times using a 1-mL pipette tip prior to filtering. The filtered 
cell suspensions were washed by centrifugation and resuspended in 80 µL of MACS buffer 
consisting of 0.5% (w/v) bovine serum albumin and 2 mM EDTA in PBS. Examination of 
cell suspensions by phase contrast microscopy immediately prior to MACS revealed that 
greater than 90% of cells were present as individual cells (supplementary data). 
 
For studies involving positive selection for CD31, 20 µL of FcR blocking reagent supplied 
with the kit (Miltenyi Biotec, Cat. No. 130-091-935) was also added. A further 20 µL of the 
required antibody-labeled magnetic micro-beads (either anti-CD31 from above kit; or anti-
CD45, Miltenyi Biotec, Cat. No. 130-045-801) were then added and the mixture incubated for 
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15 minutes at 4 °C. Each labeled suspension of cells was then washed and resuspended in 1-
mL of fresh MACS buffer before separation using a MidiMACS (LS column) system 
(Miltenyi Biotec, Cat. No. 130-042-301) according to manufacturer’s instructions. The 
separated fractions were then either processed using a second round of MACS (positive 
selection for CD31) or washed and seeded into culture plates. 
 
Immunocytochemistry 
Prior to staining, cultures were fixed for 20 minutes in neutral buffered formalin (3.7% w/v 
formaldehyde), permeabilised by treatment for 10 minutes with 0.01% (v/v) Triton X-100 
diluted in Hepes buffered saline (HBS; 0.85% w/v NaCl with 20 mM Hepes buffer at pH 7.2) 
and blocked by incubation for 30 minutes at room temperature in 2% (v/v) normal goat serum 
diluted with HBS. Cultures were subsequently incubated for 1 hour at room temperature with 
a mouse monoclonal antibody to human vWF (1:50 dilution of clone F8/86, DakoCytomation 
Cat. No. M0616) prepared in HBS supplemented with 1% (v/v) NGS. After three washes in 
buffer, the cultures were incubated for a further hour with an Alexa 488-conjugated goat anti-
mouse IgG (1:100 dilution of Molecular Probes/Life Technologies Cat. No. A11001). After 
three further washes in buffer, the cultures were counterstained for 30 minutes using 2 µg/mL 
of Hoechst 33342 nuclear dye (Life Technologies, Cat. No. H1399) diluted in HBS, then 
rinsed several times in PBS prior to imaging using a Nikon TE2000-U fluorescence 
microscope. Fluorescence micrographs were obtained using a CoolSNAP cooled CCD camera 
and labeled montages created using Adobe Photoshop. Our immunostaining protocol was 
validated through use of an external positive control (HUVEC), external negative control 
(HUVEC stained with secondary antibody only) and internal negative control (limbal 
fibroblasts). 
 
Uptake of acetylated LDL 
The phagocytosis of acetylated LDL is a characteristic of endothelial cells and macrophages. 
In a culture of unknown cells, this attribute can be used to differentiate endothelial cells from 
smooth muscle cells, pericytes and fibroblasts (Voyta et al., 1984). Sub-confluent cultures 
grown in 24-well plates were washed and incubated (37 °C for 4 to 6 hours) with MCDB-131 
(Gibco) containing 2% (v/v) FBS and 10 µg/mL acetylated LDL conjugated to Alexa Fluor 
488 (Molecular Probes/Life Technologies Cat. No. L23380). The cultures were then rinsed 
with fresh medium and cultured for a further 16 hours at 37 °C before fixation with neutral 
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buffered formalin (20 min). The CD31-negative fraction containing predominantly fibroblasts 
was utilized as a negative control.  
 
Establishment of cultures on Geltrex™ 
Geltrex™ solution (Life Technologies Cat. No. A1413201) is a viral-free formulation of 
basement membrane proteins extracted from murine Engelbreth-Holm-Swarm tumor cells 
(traditionally marketed as Matrigel® by Corning). Geltrex™-coated culture plates were 
prepared by adding 150 µL of ice-cold Geltrex™ solution per well of a 24-well plate, 
followed by incubation at 37 °C for 30 minutes to promote gelling of the matrix. The CD31-
positive and CD31-negative MACS fractions from donor limbal stroma were subsequently 
grown for one week prior to immunostaining for vWF.   
 
Statistical analyses 
For the first 12 tissue samples processed using MACS (one round of positive selection for 
CD31), tissue donor age and the length of time in storage were examined for an effect on 
culture purity using a multiple regression test (GraphPad InStat V 3.1a). All MACS 
treatments were subsequently analysed for statistical significance (compared to non-MACS 
processed cohort) using a non-parametric ANOVA (Kuskall-Wallis test with Dunn’s Multiple 
Comparison’s test; GraphPad InStat V 3.1a).  
 
 
Results 
 
Analysis of cultures established using MesenCult-XF system 
We have previously noted that limbal stromal cell cultures established and passaged using the 
MesenCult-XF system, contain a significant number of CD141/thrombomodulin expressing 
cells (approximately 40%), when compared to those grown in serum-supplemented (10% 
FBS) growth medium (<5%) (Bray et al., 2012, Bray et al., 2014). Since CD141 is expressed 
on the surface of vascular endothelial cells, we hypothesized that these same cultures might 
also express CD31/PECAM-1, a more specific marker for vascular endothelial cells. Re-
analysis of the same cultures characterised previously, confirmed our previous findings 
regarding CD141 expression (data not shown), however, negligible numbers of CD31-
positive cells were observed under either of the growth conditions tested (Figure 1). In 
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contrast, 100% of human umbilical vein endothelial cells (HUVEC, positive control) 
expressed CD31.  
 
Refinement of L-MVEC isolation method using MACS 
Overview of studies: In light of the negative results achieved above, we established a series of 
new limbal stromal cell cultures from a total of 27 cadaveric tissue donors, using culture 
conditions similar to those used for establishing microvascular endothelial cultures from other 
tissues (Karasek, 1989, Kim and Kim, 1991, Scott and Bicknell, 1993). Moreover, we 
examined the potential benefits of magnetic assisted cell sorting (MACS) used in conjunction 
with Versene treatment, as tools for improving the purity of resulting cultures. Given the low 
numbers of endothelial cells expected from each tissue sample (<10,000 cells per tissue), 
refinements in our methodology were made sequentially using a series of 3 to 6 tissue donors 
in order of presentation. The presence of vascular endothelial cells in resulting cultures was 
determined by immunostaining for von Willebrand factor (vWF) after approximately 1 week. 
The results obtained for the 27 sequential tissue donors are summarized in Table 1.  
 
Baseline cultures grown without use of MACS: The first three tissue donors were aged 
between 32 and 80 years at time of death, and their tissue samples had been stored from 
between 3 to 11 days prior to analysis. Collagenase-digests from each donor produced viable 
cultures, with the majority of cells displaying a mesenchymal morphology typical of limbal 
fibroblasts (Ainscough et al., 2011). Less than 1% of cells growing in each culture, however, 
were positive for vWF.  
 
Cultures established following one round of positive selection for CD31: The subsequent six 
tissue donors were between 32 and 64 years of age and their tissue samples had been stored 
from between 4 to 10 days prior to analysis. Tissue from these donors was digested as 
previously, but one round of positive MACS selection for CD31 was employed prior to 
culture. Cultures derived from the CD31-negative fraction typically displayed cells with a 
mesenchymal morphology amongst small clumps of tissue debris (Figure 2A). In contrast, 
epithelial islands were sporadically observed in cultures derived from the CD31-positive 
fractions (Figure 2B). The cells within these epithelial islands were subsequently confirmed 
as vascular endothelial cells by staining positively for vWF (Figure 3). Further confirmation 
of phenotype was obtained by demonstration of aligned cell-cell networks when cultivated on 
Geltrex™ and by uptake of acetylated LDL (Figure 4). Between 9 to 59% of cells in cultures 
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derived from the CD31-positive fraction of each digest stained positively for vWF. In 
contrast, less than 5% of cells in cultures derived from the CD31-negative fraction were 
typically stained for vWF. On one occasion, however, similar proportions of vWF-positive 
cells were observed in cultures established from both the CD31-positive and CD31-negative 
fractions (18 and 16% respectively).  
 
Effect of Versene treatment on culture purity: Given the occasional presence of vWF-positive 
cells in the CD31-negative fractions observed above, we hypothesized that some CD31-
positive cells might have been trapped within clumps of CD31-negative cells thus leading to 
their presence in cultures derived from the CD31-negative fraction. In an effort to reduce this 
apparent loss of CD31-positive cells, tissue obtained from the subsequent 6 donors was 
briefly treated with Versene prior to positive MACS selection for CD31. Analysis of cell 
suspensions by phase contrast microscopy immediately prior to MACS confirmed that >90% 
of cells were present as individual cells with only the occasional small clump of cells 
(supplementary data). This series of tissue donors were aged between 31 and 80 years and 
their tissue had been stored for between 2 to 8 days prior to analysis. Cultures derived from 
the CD31-positive fraction of 5 tissue donors contained between 4-77% vWF-positive cells. 
The majority of cells contained in cultures derived from the CD31-negative fraction were 
once again negative for vWF (<5%) with the exception of cultures derived from donor 12 
(15% compared with 14% for CD31-positive fraction).  
 
Cultures established following two rounds of positive selection for CD31: Despite the 
continued occasional presence of vWF-positive cells in the CD31-negative MACS fraction, 
the combined results obtained from the first 12 MACS-treated tissue samples had 
demonstrated a clear trend towards more purified cultures when positive selection for CD31 
had been used (average ± s.e.m of 24.3 ± 7.0% compared to 3.6 ± 1.7% for CD31-negative 
fraction). Neither donor age nor time-in-storage were found to correlate with improved 
success for these first 12 donors (using multiple regression test). We subsequently 
hypothesized that an increase in purity might be achieved if two rounds of positive selection 
for CD31 were used. The following 6 donor tissue samples were therefore processed using 
this strategy with the Versene treatment being retained. For this series the donors were aged 
between 50 and 72 years and the tissue had been stored for between 4 to 11 days prior to 
digestion with collagenase. All cultures derived from both CD31-negative fractions for each 
donor, consistently contained low numbers (<5%) of vWF-positive cells (Table 1, Donors 16-
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21). In contrast, cultures derived from the CD31-double positive fractions for three donors 
contained between 15-98% vWF-positive cells for three donors (average ± s.e.m, 65.0 ± 
20.8%). This result was found to be statistically different to the baseline cultures established 
without use of MACS (Figure 5, non-parametric ANOVA with Dunn’s multiple comparisons 
test, p<0.05). The remaining three donor CD31-double positive cultures contained insufficient 
numbers of cells required to support a meaningful analysis (<100 cells in each well). 
 
Effect of removing CD45-positive cells: Finally, as an alternative to two rounds of positive 
MACS selection for CD31, we trialed the use of negative MACS selection for CD45 followed 
by one round of positive MACS selection for CD31. This approach was examined given the 
potential presence of CD45+/CD31+ cells of myeloid lineage in tissue digests. The tissue 
samples used for this series of cultures were obtained from donors aged between 48 and 72 
years and had been stored for between 5 to 9 days prior to digestion. Cultures derived from 
the resulting CD45-/CD31- fractions consistently contained less than 5% vWF-positive cells 
(Table 1, Donors 22-27). In contrast, cultures derived from the CD45-/CD31+ fractions 
generally contained between 12-35% vWF-positive cells (average ± s.e.m, 25.0 ± 4.8%). Poor 
growth was observed in cultures derived from both fractions on only one occasion. 
 
 
Discussion 
 
Given the prominent role of the limbal microvasculature in health (stem cell niche) and 
disease (corneal neovascularization) it is surprising to find so few studies of prior attempts to 
isolate and grow human L-MVEC. A search of the PubMed database for example using the 
search term “limbal microvascular endothelial cells” retrieves only one relevant paper, where 
Marceau and colleagues (1990) reported remarkable success in growing human L-MVEC. An 
alternative search using “limbal vascular endothelial cells” returns over 140 papers with the 
majority of studies being unrelated to the topic of L-MVEC culture. Indeed the only three 
additional papers that we can find of direct relevance to human L-MVEC culture are those by 
Garfias et al (2012) and Li et al (2012a, 2012b) who, like ourselves (Bray et al., 2012, Bray et 
al., 2014), have apparently come to explore the question of human L-MVEC culture through 
an interest in studying the properties of limbal stromal progenitor cells. Locating prior studies 
is notably complicated by a much larger body of literature on the non-vascular, but similarly 
named, corneal endothelial cells (approximately 5000 papers as of August 2014). 
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Our initial interest in human L-MVEC arose from our recent observations of marked CD141 
expression in cultures of limbal stromal cells grown in a commercial serum-free medium 
(Bray et al., 2012, Bray et al., 2014). While CD141 is not exclusively expressed on the 
surface of vascular endothelial cells, it’s presence is consistent with an endothelial cell 
phenotype and so we commenced our present study by re-evaluating our established cultures 
for evidence of a more specific marker, CD31/PECAM-1. As shown clearly in Figure 1, 
however, our CD141+ cultures contain no evidence of CD31 expression and as such the 
expression observed previously in our limbal stromal cultures (grown using the MesenCult-
XF system) is therefore more likely to be due to contaminating epithelial cells which have 
also been found to express this marker (Ikeda et al., 2000). 
 
Techniques for growing microvascular endothelial cells typically involve use of gelatin-
coated culture dishes and growth media containing a variety of specialist components 
including heparin (Scott and Bicknell, 1993). After the failure of MesenCult-XF to support L-
MVEC growth, we therefore switched to more traditional endothelial cell growth conditions 
for our first three tissue donors. These cultures were also to serve as a baseline for subsequent 
donor cultures established with aid of MACS. The resulting low-level of vWF staining 
observed under these conditions (Table 1, donors 1-3), however, clearly demonstrates that use 
of such conditions alone, are insufficient to generate L-MVEC cultures of any significant 
value. While this result differs from the original observations of Marceau et al., (1990), these 
authors grew their cultures from tissue explants rather then dissociated cells and the initial 
cellular outgrowth that they observed, was only determined to be microvascular endothelial 
cells based upon a “cobblestone, polygonal” morphology. In our experience, these 
observations are more consistent with epithelial outgrowth derived from limbal epithelial 
progenitor cells (Harkin et al., 2013). Moreover, the positive immunostaining for vWF in 
passaged mesenchymal cultures reported by Marceau et al. (1990) was not validated through 
demonstration of a negative control. Nevertheless, our own findings do agree with those of 
Marceau et al., with respect to highlighting the problem of contamination with other cell 
types, and this mirrors similar findings with endothelial cell isolation from other tissues (Scott 
and Bicknell, 1993). In the present study, the extensive growth of fibroblastic cells in cultures 
derived from crude stromal tissue digests, suggested to us that some from of purification step 
would be required in order to increase L-MVEC culture purity.  
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Given the low numbers of cells extracted from each tissue sample, we chose to explore 
magnetic assisted cell sorting (MACS), encouraged also by prior observations of CD31-
positive cells in collagenase-digests of human limbal stroma (Li et al., 2012b). On viewing 
the combined results from our 27 donor tissue cultures, it is apparent that vWF+ cells can be 
routinely observed in cultures established following at least one round of positive MACS 
selection for CD31. Moreover, the purity of L-MVEC cultures is significantly increased by 
use of double positive selection for CD31 (p<0.05 by one-way ANOVA). Multiple rounds of 
MACS, however, negatively impact on yield since only 7 out of the last 12 donor cultures 
produced sufficient cell numbers for analysis. The unexpectedly similar numbers of vWF+ 
cells in cultures established from both CD31-positive and CD31-negative fractions observed 
for donors 5 and 12, are considered to have resulted from poor digestion combined with an 
overall reduction in cell numbers due to the MACS protocol (low temperatures and non-
specific capture within columns).  
 
A notable feature of the L-MVEC cultures established in this study is that the cells typically 
formed epithelial–like islands similar to those reported for microvascular endothelial cells 
cultivated from other tissues including rat lung (Kim and Kim, 1991), human skin (Karasek, 
1989) and human brain tissue (Bernas et al., 2010). We have also achieved similar results for 
microvascular endothelial cells isolated from human choroid using MACS selection for CD31 
(un-published data). This morphology differs quite considerably from the prior observations 
of Li et al (2012a, 2012b) who demonstrated a mesenchymal morphology for passaged 
cultures of vWF+ cells established from human limbal stroma. We propose that the difference 
in morphology is due to varying degrees of cellular differentiation observed according to 
differences in culture methods, as has been reported previously for vascular endothelial cells 
cultivated from other tissues (Scott and Bicknell, 1993). More specifically, we consider that 
by using MACS selection for CD31 we have isolated a more mature population of vascular 
endothelial cells with a more epithelial morphology and more limited potential for 
proliferation. Indeed, our attempts to passage primary L-MVEC cultures from either 
cadaveric limbus or choroidal tissue have generally resulted in poor results especially when 
initial cell numbers are low (In the case of choroidal cultures this problem can be somewhat 
avoided through starting with a greater quantity of tissue). Alternatively, cultures generated 
through pre-expansion of crude tissue digests in serum-supplemented growth medium 
followed by suspension in Matrigel® (as performed by Li et al. (2012a, 2012b)), apparently 
gives rise to cells with a more mesenchymal morphology and greater potential for 
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proliferation. It is also possible that other cells types present within crude tissue digests are 
necessary to promote the expansion of L-MVEC progenitor cells. For example, pericytes have 
an established role in promoting corneal vascularization in vivo (Ozerdem et al., 2005). We 
have detected CD146-positive cells (a marker for pericytes) in crude cultures of limbal 
stromal cells grown in serum supplemented growth medium (Bray et al., 2014), but these cells 
may well need to be growth-arrested (using either gamma radiation or mitomycin C) prior to 
co-culture with L-MVEC, in order to avoid these cells from dominating the culture. 
 
Conclusions 
Our studies demonstrate the feasibility of isolating limbal microvascular endothelial cells (L-
MVEC) from human cadaveric corneal-limbus using magnetic assisted cell sorting (MACS). 
While specialist growth conditions designed for endothelial cell culture may well be 
necessary, these conditions are insufficient to generate cultures of sufficient purity for 
subsequent studies. Through use of positive MACS selection for CD31/PECAM-1, however, 
we have been able to generate cultures containing clear evidence of microvascular endothelial 
cell growth, and two rounds of positive selection significantly increase culture purity to up to 
greater than 60%. The L-MVEC cultures generated with aid of MACS display an epithelial 
morphology and typical endothelial cell responses to growth on Geltrex™ and treatment with 
acetylated LDL. We propose that the L-MVEC cultures generated through use of MACS will 
provide a useful tool for exploring the role of these cells in both health (limbal stem cell 
niche) as well as diseases of the cornea associated with neovascularization. 
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Table legend  
 
 
Table 1. Comparison of protocols for L-MVEC isolation. This table summarizes the results 
obtained when attempting to cultivate L-MVEC from 27 sequential donor tissue samples. 
Owing to the small numbers of cells obtained from each donor, tissue samples were organized 
into five different processing cohorts. All samples were grown for approximately 1 week 
under conditions designed to promote growth of vascular endothelial cells. The presence of 
vascular endothelial cells was determined by immunocytochemistry for vWF and expressed 
as a percentage of the total cells counted (determined by staining with Hoechst nuclear). At 
least one hundred cells were examined and scored per culture. Cultures with less than 100 
cells were excluded from analysis and recorded as “poor growth”.  
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Figure legends 
 
 
Figure 1. Examination of crude limbal stromal cell cultures for evidence of vascular 
endothelial cells. Early passage cultures (p 1-2) of limbal stromal cells (LSC) were grown in 
either DMEM supplemented with 10% (v/v) foetal bovine serum (LSC 10% FBS) or using 
the MesenCult-XF system (LSC MesenCult). The potential presence of vascular endothelial 
cells was examined by flow cytometry for CD31. Human umbilical vein endothelial cells 
(HUVEC) are used as the positive control. Results obtained using isotype antibody controls 
are displayed in red. The analysis demonstrates negligible numbers of vascular endothelial in 
cultures established from limbal stroma. 
 
 
Figure 2. Comparison of cultures established following MACS selection for CD31 and grown 
under conditions designed to promote vascular endothelial cell growth. (A) Typical 
appearance of culture established from the CD31-negative fraction of collagenase-digested 
limbal stroma after one week. With the exception of what appears to be tissue debris, the 
culture predominantly contains adherent cells displaying a mesenchymal phenotype. (B) 
Appearance of culture established from the corresponding CD31-positive fraction (same 
donor tissue) after one week. Despite the continued presence of mesenchymal cells, some 
small islands of epithelial-like cells are also observed (labeled with white arrow). 
 
 
Figure 3. Screening of stromal cultures by immunostaining for vWF. (A) Negative control 
displaying confluent HUVEC culture stained with Hoechst nuclear dye. (B) Same culture as 
in panel A, but displaying negative control pattern of staining for secondary antibody alone 
(Alexa-488 goat anti-mouse IgG). (C) Positive control HUVEC culture displaying distribution 
of staining for Hoechst nuclear dye. (D) Same culture as in panel C, but showing pattern of 
positive control staining for vWF. (E) Pattern of Hoechst staining for test culture (Donor 5 in 
Table 1) derived from CD31-positive fraction of collagenase digested limbal stroma. (F) 
Same field of cells displayed in E, but revealing islands of vWF-positive cells. (G) Pattern of 
Hoechst nuclear staining for test culture established following negative selection for CD45 
prior to positive selection for CD31. (H) Same field of cells displayed in G, but revealing 
extended islands of vWF-positive cells. 
 
 20 
 
 
 
Figure 4. Functional studies of L-MVEC cultures. The phenotype of cultured L-MVEC was 
further confirmed by greater uptake of fluorescent labeled acetylated-LDL by cells within the 
CD31-positive fraction of cells isolated from the human limbal stroma (A) compared with 
cultures derived from the CD31-negative fraction (B). Moreover, cultures derived from the 
CD31-positive fraction, contained vWF-positive cells that formed aligned cell-cell networks 
(trains) of connected cells when cultured on Geltrex™ (C) compared to the more epithelial-
like islands observed in cultures established in gelatin-coated culture dishes (D). 
 
 
Figure 5. Graphical representation of combined results for comparison of protocols. Bars 
represent the mean ± sem percentage purity of vWF-positive cells observed in week-old 
cultures from each donor tissue. Labels on “X” axis refer to initial tissue digestion protocol. 
Labels above each bar indicate the MACS fraction from which cultures were derived. 
Asterisk indicates significant difference compared to the crude cultures established without 
use of MACS. R1 and R2 indicate first and second rounds of MACS selection respectively. 
 
 
 
Supplementary data figure: 
Phase contrast image of processed limbal tissue digest following treatments with collagenase, 
Versene and resuspension in MACS buffer. The majority of cells can be observed 
individually (white arrows) with only one small clump of 2 cells being observed in this field 
(black arrow). Numerous fibrous clumps of extracellular matrix (ECM) components can also 
be seen.  
 
 
 
 
 
 
 






